A detailed history of Foundations Investment Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Foundations Investment Advisors, LLC holds 161,950 shares of CRDL stock, worth $207,296. This represents 0.01% of its overall portfolio holdings.

Number of Shares
161,950
Previous 48,000 237.4%
Holding current value
$207,296
Previous $96,000 233.33%
% of portfolio
0.01%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$1.83 - $2.48 $208,528 - $282,596
113,950 Added 237.4%
161,950 $320,000
Q2 2024

Aug 02, 2024

BUY
$1.67 - $2.97 $80,160 - $142,560
48,000 New
48,000 $96,000

Others Institutions Holding CRDL

About Cardiol Therapeutics Inc.


  • Ticker CRDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 61,942,500
  • Market Cap $79.3M
  • Description
  • Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...
More about CRDL
Track This Portfolio

Track Foundations Investment Advisors, LLC Portfolio

Follow Foundations Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundations Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundations Investment Advisors, LLC with notifications on news.